image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

CVS Group

January 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CVS
  • Price:
  • 1531p
Buy-and-build veterinary services group CVS said total sales rose 11.9% (like for like +5.8%) in the four months to 31 October. Adjusted EBITDA margins remained unchanged from the prior period at 19% reflecting continued investment in support functions and clinical care. Its Healthy pet club preventative care scheme increased membership from 479,000 to 499,000 members. In terms of acquisitions it completed another four small animal practice deals bringing the total to nine (11 practice sites) year to date. The uncertainty caused by the CMA review has caused weakness in the shares but when resolved that may provide a good entry point up ahead. The prospective PE is now just 16 (eps: 95.8p). I’m holding on.< ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

CVS Group (November 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe

SUBSCRIBE NOW